Picture of Zenova logo

ZED Zenova News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapSucker Stock

REG - Zenova Group PLC - Annual Results for the period ended 30 Nov 2023

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240607:nRSG4970Ra&default-theme=true

RNS Number : 4970R  Zenova Group PLC  07 June 2024

7 June 2024

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK
VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 ("MAR") WHICH IS PART OF
ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS
INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

Zenova Group PLC

("Zenova", the "Company" or the "Group")

 

Annual Results for the period ended 30 November 2023

 

Zenova Group PLC (AIM: ZED), the innovative fire suppression and interdiction
company, today announces its results for the year ended 30 November 2023. In
addition, the Company gives notices of its annual general meeting ("AGM") and
the publication of its annual report and accounts.

 

Highlights For The Year Ended 2023

·     Sales of £278k for the year ended 30 November 2023 (2022 - £175k),
an increase of 59% over the prior year of £175k.  Sales were impacted by
delays in gaining key product certifications required to enter strategic
market segments.  These issues have now all been resolved and the Company
anticipates significant revenue growth in the near term.

·     Loss after taxation for the year of £1,687k, a decrease of 17% from
the prior year (2022 - 2,032k) mainly arising from R&D tax credits, costs
of research and development, testing and certification, staff costs, and
professional fees.

·      Multiple, significant testing and certification commendations
including BRE steel testing confirming the effectiveness of Zenova FP fire
retardant paint, Liverpool John Moores University validation for the Zenova IP
thermal insulation paint, certification (Classes A, B, F and Electrical) for
the FX500 aerosol fire extinguishers to BS6165 fire standard, and European
EN3-7 testing and certification for the Company's larger FX 6L and 9L
extinguishers confirming Classes A, B, and F, as well as Electrical
classification.

·    Successful launch of all major Zenova products from the FP fire
retardant coatings, IP insulation coating and IR insulation render comprising
its paint-related offering, to its extinguisher suite of products which
include the smaller FX500 aerosol, and the larger 6 and 9 Litre all-in-one
extinguishers, all of which are effective on all types of fire, as well as the
FX fluid, a certified extinguishing agent for any type of fire and finally,
the WB, eco-friendly, nontoxic wildfire barrier.

·    Sales prospects enhanced significantly through concentrating on
direct B2B accounts across multiple sectors and through appointing
sub-distributors and sales agents both in the UK and internationally.
Several of the latter agreements include annual minimum purchase quantities by
value guarantees in order to maintain Zenova product exclusivity.

·    New customers and leading distributors engaged in fiscal year 2023
included Dulux, Rawlins Paints, Kensington and Chelsea local authority, Melin
Homes, Pinewood Studios, the NHS, Enfield City Council, Together Housing,
Southdown Housing Association, Ukraine Military, Omnis (USA), Zensafe Ltd and
Clastrom (Germany).

·      Sales prospects were further enhanced through a successful
demonstration of the leading-edge capabilities of Zenova's entire FX range of
extinguishers to leading UK Government officials and Fire Industry Experts at
the Fire Service College, Moreton-in-Marsh, in November 2023.

·      Zenova strengthened its supply chain by signing manufacturing
partners across the UK, Europe, and North America for all Zenova products,
improving our preparedness to meet the demands of growing order book
projections.

·      Board realigned and strengthened through the elevation of Fiona
Rodford to Executive Vice-Chairperson, with Don Nicolson reverting back to the
role of Non-Executive Chairman.  Thomas Melchior was appointed Interim Chief
Executive Officer, with Tony Crawley assuming the non-board role of Sales
Project Director, while Farakh Farid was appointed to the non-board role of
Chief Financial Officer.

·      In May 2023, the Company successfully raised gross proceeds of
£500,000 through a placing at 4 pence per share. In addition, participating
investors were granted a warrant carrying an exercise price of 10 pence per
share and expiring three years from the date of issue.

 

Post Year End Highlights

·      Zenova expanded and deepened its partnership with
Gracewood/Drips and Sparks/Zensafe with a £2.4 million order over two years
for FP paint. (April 2024). Early returns from this order are beginning to be
realised as the construction season gets underway.

·       The Zenova FX extinguisher range earned further major
accreditations, notably the UK Kitemark, and MED (Marine Equipment Directive)
certifications, both in 2024, establishing the Zenova extinguishers as the
premier certified choice for comprehensive fire protection across any fire
type.

·      Zenova expanded its efforts to bring its products closer to
international customers through successful client demonstrations in Mallorca,
Spain (March 2024) and Albania (May 2024).

·      Zenova global sales footprint expanded to Latin America (2024),
India (2024) and Romania (2024).

·      Fiona Rodford assumed the role of Non-Executive Chair of the
Company, replacing Don Nicolson. (March 2024).

·      To fund its growth efforts, Zenova successfully raised gross
proceeds of £677,500 through a subscription, earmarked to strengthening
working capital. (March 2024).

·      Zenova appointed a new broker, Peterhouse Capital, and a new
auditor, Gravita. (April 2024).

·      Zenova discontinued director working capital loan facility of
£350,000 (May 2024).

 

Outlook

We foresee the promising convergence of positive macro tailwinds in the fire
interdiction markets, continued, recognised certification separation between
the Zenova product range and the competition, and further exploitation of the
Group's growing distributor relationships, which will drive accelerating sales
growth for Zenova through the rest of 2024 and beyond.

 

Thomas Melchior, Chief Executive of Zenova Group PLC commented: "It has been
another challenging year for Zenova as delays to product certifications slowed
somewhat the rollout of our B2B strategy internationally.  These issues are
now largely behind us as the recent Drips and Sparks/Gracewood/Zensafe
multi-year, multi-million-pound order demonstrates. We are entering 2024
focused on execution: delivering on existing business, opening new markets and
client relationships, and serving our growing customer base as they upgrade
their fire protection and thermal insulation needs."

 

Notice of AGM and Publication of Annual Report

The Company gives notice that its AGM will be held at 10.00am BST on 2(nd)
July 2024 at the offices of Zenova Group Plc, 172 Arlington Road, London NW1
7HL.

The Notice of AGM, along with the Company's annual report and accounts for the
year ended 30 November 2023 (together, the "Documents"), have been published
on the Company's website at: https://zenovagroup.com/reports-documents/. The
Documents, along with a form of proxy, will be posted to those shareholders
who have elected to receive physical copies today.

 

For further information please contact:

Zenova Group PLC

Thomas Melchior, Chief Executive Officer                Via
Orana Corporate LLP:

Fiona Rodford, Chair
                                   Anthony
Eastman

Tel: +44 20 3475 6834

 

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis / Adam
Dawes
Tel: +44 20 3368 3550

 

Peterhouse Capital Limited (Broker)

Charles Goodfellow / Rose Greensmith
Tel: +44 207 469 0930

 

 

 

Chair's Statement

Dear Shareholders,

Zenova was founded to develop innovative, sustainable solutions within the
fire safety and heat management industry. Since our IPO in 2021, we have
developed, tested, certified, and launched a suite of fire safety and
temperature management products and solutions.

Through innovative development, and a refined formulation and development
process, Zenova provides industry-leading solutions across a range of fire
protection and temperature management problems, comprising fire retardant
paints, insulating paints and render, fire extinguishing fluid, and a range of
fire extinguishers.

Over the past year, Zenova's products have been rigorously tested and
certified by independent, industry experts and testing houses:

·    BRE steel testing confirmed the effectiveness of our fire-retardant
paint.

·    Liverpool John Moores University validated the efficiency of our
thermal insulation paint, which can deflect, absorb and dissipate heat and
reduce temperatures by up to 45% and therefore save costs, and reduce thermal
conductivity.

·    Zenova FX fire extinguishers are now tested and certified to the
highest standards, including EU EN3-7, and post period also achieved UK
Kitemark and MED certification. We believe we now have the best all-in-one
fire extinguishing fluid, capable of extinguishing any type of fire.

Zenova has strengthened its supply chain and now has scalable, outsourced
manufacturing in the UK, Europe and in North America with reliable
manufacturing partners ready to scale production.

Our global sales and delivery capabilities have been further enhanced through
the appointment of sales and sub-distribution partners. Our global sales
footprint now covers all major markets, including the USA, Latin America
(2024) and the UK with expanded distribution partners such as Rawlins, Dulux.
Our international expansion into promising markets like Germany, India (2024)
and Romania (2024) further extends our sales and distribution network.

Zenova products have been specified for use in construction projects,
renovations, film productions and production site safety by local government
bodies, commercial entities, and social housing projects.

Our sales and marketing strategy, including effective product demonstrations
in the USA, UK, Palma (2024) and Albania (2024) is further supporting our
sales efforts.

The Zenova Group has achieved much in 2023, but sales growth has been lower
than expected with Zenova recording £278k in the year ended 30 November 2023,
which was a significant improvement over 2022, but nevertheless short of our
expectations.  Sales were impacted by delays in key product certifications
required to enter key market segments. These issues have now all be resolved,
and the Board expects significant revenues growth in 2024.  This belief is
underlined with the recent £2.4m Gracewood order and the significant sales
prospect pipeline.

The Board believes that Zenova is well positioned for significant revenue
growth in this fiscal year, benefiting from our hard work and achievements in
securing the highest levels of certification and closing major sales
agreements over the past years.

Alongside this we are committed to a programme of rigorous cost management,
with monthly budget reviews at the Board level to ensure sufficient working
capital during this growth period. We also expect Research and Development
costs to decrease significantly as we move into the next phase of our
strategy.

Zenova raised £500k gross through a placing of shares combined with
three-year warrants with an exercise price of 10 pence per share in May 2023
as well as an additional £678k gross in March 2024 through a subscription,
earmarked for bolstering working capital.

We also made some personnel changes to allow us to strengthen our deliver
focus by moving Tony Crawley, Chief Executive Officer, to the role of Sales
Project Director. Thomas Melchior, previously Chief Financial Officer, was
appointed as interim Chief Executive Officer and I was appointed as Executive
Vice Chair. In March 2024, I assumed the role of Non-Executive Chair of the
Company.

I wish to thank Don Nicolson, the previous Chairman of Zenova since the IPO,
for his active guidance and wisdom of steering the company successfully.

Our goal is to establish Zenova as the trusted provider of fire safety and
thermal management solutions and products across multiple sectors and
geographies.  We are very confident in the effectiveness of our products,
which have now been established through rigorous testing, certification,
trials, and backed by customer trials and experience.

As always, a business depends on the goodwill of its people, and I wish to
express my gratitude to our dedicated employees, loyal customers, and
supportive shareholders. Together, we are well-positioned for continued
success and profitable growth. We believe that Zenova and its products have a
bright future and look forward to updating the market with further
developments.

 

Fiona Rodford

Chair

Zenova Group PLC

6(th) of June, 2024

 

Strategic Report by the Chief Executive

Introduction

Zenova Group, through Zenova Ltd, is the holder of intellectual property that
underpins a suite of fire safety and temperature management products and
technology. The product range is applicable to industrial, commercial, and
residential markets. The Group's products include fire retardant paints,
insulating paints and render, fire extinguishing fluid and fire extinguishers.
Through innovative development, and a refined formulation and development
process, Zenova provides industry leading solutions across a range of fire
protection and temperature management problems.

The founders of Zenova Group leveraged their extensive experience in the fire
safety and insulation industry and began their research and development in
2017. A significant motivation for forming Zenova Group was the perceived
stagnation in technological advancements within the fire safety sector. For
over fifty years, the field had seen minimal innovation, leaving firefighters
worldwide reliant on outdated technology that is resource-intensive and often
produces harmful by-products.

Recognizing a significant market gap, the founding team developed innovative
fire deterrence methods, starting with fire extinguishing fluid and associated
hardware systems. Encouraged by positive test results, the founders expanded
their product development to include paints and renders. By using innovative
formulations and refining the development process, the team produced
industry-leading solutions for various fire protection and temperature
management challenges.

Zenova Ltd was established on January 20, 2020, to commercialize the
intellectual property created by the founders. On July 22, 2021, Zenova Group
Plc was admitted to AIM, raising £4.5 million before costs.

Research and Development, Testing and Certification

Zenova Group is committed to continuously developing and improving its
products in order to maintain its competitive advantage.

Zenova has a small research and development team, as well as industry leading
partners engaged under consulting agreements. Their task is product
development, testing and refining the formulas and processes used for to
create the Zenova intellectual property. In addition to the development of
products, Zenova's R&D efforts also focus on rigorous and continuous
testing, trials and certification.

·    BRE steel testing confirmed the effectiveness of our Zenova FP,
fire-retardant paint, thus expanding market potential for our Zenova FP
intumescent coating.

·    Liverpool John Moores University validated the efficiency of our
Zenova IP thermal insulation paint and successfully demonstrated that just 1mm
of Zenova IP can move a building's EPC rating from E to D, reducing heat
energy consumption by over 25% thus lowering fuel bills by improving the
U-value by 35%. Liverpool John Moores University our thermal insulation paint,
which can deflect, absorb and dissipate heat and reduce temperatures by up to
45% and therefore save thermal management energy costs.

·    Certification test results for the Zenova FX500 aerosol fire
extinguisher by international testing house CNBOP, an international testing
house confirming Classes A, B, F and Electrical classification to the BS 6165
fire standard.

·    Zenova's FX extinguisher range passes EN3-7 testing and certification
for the Zenova FX 6L & Zenova FX 9L extinguishers by MPA Dresden Fire in
Germany, confirming Class A, B, F and Electrical classification to the latest
EN3 standard.

Post period updates

·    The Zenova FX extinguisher range further passed UK Kitemark, and MED
(Marine Equipment Directive) certifications, both in 2024, establishing the
Zenova extinguishers as premier certified choice for comprehensive fire
protection across any fire type.

Products & Solutions

Zenova has developed a range of products providing fire safety and heat
management solutions for a wide range of sectors and environments.

Zenova FP, fire protection paint

A water based, fire protection paint (also known as a 'thermofoaming' or
'intumescent' paint), which can be used on any surface and colour matched to
any colour. When exposed to heat or flames, the paint expands and creates a
solid foam-like crust which will not burn and insulates the surface to which
it is applied. This prevents surfaces from catching fire and stops fire
spreading.

Zenova IP, thermal insulation paint

A thermal insulation paint embeds the most modern insulating technology in a
thermos-like ultra-thin layer. It saves energy by increasing the thermal
insulation level in commercial and residential buildings.  Zenova IP has been
independently tested and validated to deflect, absorb and dissipate up to 75%
of this heat, thereby reducing the inside temperature by up to 45%.  Suitable
for both exterior and interior surfaces, on any type of surface.

Zenova IR, thermal insulation render

Zenova IR is a ready mixed insulation render that can be applied to internal
and external walls in commercial and residential buildings to provide
immediate insulation benefits and can be colour matched to any colour.

Zenova FX, fire extinguishers

A fire extinguisher like no other. Zenova FX extinguishers are PFAS compliant,
effective and safe to use on all types of fires. Fully tested to European
EN3-7 as well as British standards, the Zenova FX extinguishers are certified
for class A, B and F as well as being safe for use on electrical fires.
Available in 6 and 9 litre sizes.

Zenova FX500, aerosol fire extinguisher

The Zenova FX500 is a high-performance handheld fire extinguisher that is
tested by independent experts and adheres to the highest industry standards.
Safe for use on any type of fire, the Zenova FX500 reduces the risk of
reignition. The Zenova FX 500 is quick, easy and safe to operated and has been
fire tested to BS6165 standard.

Zenova WB, wildfire barrier

A wildfire barrier fluid (applied via spray wands or aerial drops), which
provides a virtual barrier where fire simply will not burn. Repeated tests by
the Wildfire Laboratory at Exeter University on a variety of extremely dry
wildfire fuels (grasses, hays, brush) confirms the incredible fire resistance
Zenova WB provides, while remaining viable after application for 30+ days in
dry conditions.

Sales

Zenova sales strategy is currently concentrated on large business-to-business
accounts in sectors such as construction, manufacturing, industrial and public
sector bodies. Zenova targets sales to the end user, by appointing
sub-distributors and sales agents on a national and international level.

Zenova focuses on product demonstrations and trials with key clients to
leverage the networks and accredited industry specific consultants to
penetrate large businesses, and public sector bodies.

Sales routes:

·    Key account sales

·    Direct sales

·    Sales agents

·    Sub distributors for paint sales and distribution

·    Fire management experts and advisors

·    International sub distributors

Product demonstrations

A key sales tool for the Company is in-person demonstration of the Zenova
product range capabilities for potential clients, fire risk management experts
and key purchasing decision makers.

·    Emergency Services Showcase in Birmingham, UK

·    Disasters Exp (https://www.ndecalifornia.com/) o USA in Anaheim, USA
(Sep 2023)

·    The Fire Service College, Moreton-in-Marsh, UK (Nov 2023)

·    Palma, Mallorca (March 2024)

·    Albania, (May 2024)

Customer trials

Zenova is following a strategy of customer trials with key customers. As a
result of these the company currently has invoiced and supplied multiple trial
orders to key segments which are expected to lead to large follow up orders.

Post period update:

Customer trials of Zenova FP coatings on steel with Gracewood Construction Ltd
through their sprayers Drips and Sparks Ltd and our sub-distributor Zensafe
Ltd led to a two-year order for 200,000 litres for Zenova FP coating.  The
order is worth £2.4million to the Company over 2 years, which will be payable
against monthly deliveries to sites specified in the previous month in
instalments, commencing immediately.

Key customers

Some of our key customers are Dulux, Rawlins Paints, Kensington and Chelsea
local authorities, Pinewood Studios, the NHS, Enfield City Council, Together
Housing, Southdown Housing Association and the Ukraine Military.

Sales and distribution network

Zenova expands global sales and delivery capabilities through appointment of
sales and sub-distributors for major market access. Zenova has secured some
cornerstone agreements within key sectors which are expected to develop into
large, longer-term sales from these partnerships.

Zenova has entered into several international sub-distributor agreements in
various territories globally. These contracts include an annual commitment
to purchase a minimum quantity by value of Zenova products.

Zenova's growing global sales and distribution footprint now covers all major
markets including:

·    UK

·    Germany

·    Austria

·    Switzerland

·    Poland

·    Spain

·    Portugal

·    Romania (2024)

·    USA

·    Latin America (2024)

·    India (2024)

 

Post period sales and distribution network update

Zenova global sales footprint has recently expanded into Latin America (2024).
International expansion into India and Romania.

Manufacturing

Zenova has strengthened its supply chain and now has reliable, scalable,
outsourced manufacturing partners for all Zenova products in the UK, Europe
and in North America which are ready to increase production to meet Zenova's
growth projections.

Manufacturing is subcontracted to specialist manufacturers in each category of
product.  Zenova sources and approves the manufacturing components and
processes used by the manufacturers in advance of first production. Zenova
maintains responsibility for ongoing manufacturing oversight and
implementation of manufacturing strategy based on forecasted product supply
and demand levels. The manufacturing process for all products and the time
scale to produce finished goods is optimized. Zenova has entered manufacturing
contracts with manufacturers to produce the initial volumes of its paints,
primers, render, firefighting fluid and fire extinguishers.

Zenova has partnered with manufacturers in the following locations:

·    Zenova FP
UK & Canada

·    Zenova
IP                                UK &
Canada

·    Zenova
IR                                UK &
Canada

·    Zenova FX500             UK & USA

·    Zenova FX6L & FX9L
Poland

·    Zenova FX fluid                      Poland
& Canada

·    Zenova WB
Poland & Canada

All production facilities are designed to scale up rapidly to meet expected
growth in demand for Zenova products worldwide.

 

Board and management

Zenova realigned the Board of Directors and senior management to focus on
sales and increasing market penetration as the company entered the next stage
of growth and focused on operational capacity to transition from R&D,
testing and certification to sales growth and customer delivery. (June 2023)

·    Don Nicolson who chaired the Board of Directors since the company was
admitted to AIM in July 2021 reverted back into the role of Non-Executive
Chairman.

·    Fiona Rodford took on the role of Executive Vice-Chairperson.

·    Tony Crawley, Chief Executive Officer, stepped down from the Board
and assumed the role of Sales Project Director.

·    Thomas Melchior (the previous CFO) was appointed as interim Chief
Executive Officer.

·    Farakh Farid was appointed to the non-Board role of Chief Financial
Officer.

Post period update.

·    Fiona Rodford assumed the role of Non-Executive Chair of the Company,
following Don Nicolson's resignation. Fiona's primary focus is on accelerating
business growth and leveraging expanding market expansion through sales and
distribution arrangements. (March 2024)

Financing

·    Directors Don Nicolson, Thomas Melchior, Etrur Albani, and Fiona
Rodford entered into a working capital loan with the Company, making up to
£350,000 of cash resources available if needed. None of the Working Capital
Loan has been utilised. The participating directors are to be rewarded for
creating this facility.

·    The Company successfully raised gross proceeds of £500,000 through a
placing at 4 pence a share. In addition to receiving placing shares, investors
participating in the placing were granted a warrant in the ratio of one
warrant for each placing share carrying an exercise price of 10 pence per
share and expiring in three years from the date of issue. Additionally, one
investor has entered into a deferred subscription agreement with Zenova
pursuant to which it has the right to subscribe for up to an aggregate of
3,750,000 ordinary shares at 10 pence per ordinary shares within three years
from the date of issue. (June 2023)

Post period updates

·    Zenova appointed a new broker, Peterhouse Capital, and appointed
Gravita as its new auditing firm. (April 2024)

·    To fuel its expansion efforts, Zenova successfully raised gross
proceeds of £677,500 through a subscription, earmarked to strengthen working
capital. (March 2024)

·    With robust projected cash flows and recent funding initiatives,
Zenova discontinued the director working capital loan of £350,000, as it is
not been drawn down and was no longer deemed necessary. (May 2023)

The Future

We anticipate that the next twelve months will be focussed on sales order book
growth and order execution with a close focus on working capital management.

Zenova is already seeing a significant increase in qualified sales leads and
quotations and expects conversion to orders will grow at an increasing pace as
its sales and distribution channels gear up.

In the meantime, the Group has implemented strict cost controls to ensure it
has the working capital to navigate this period of growth.

Finally, I would like to thank our dedicated employees, our Board colleagues
for their support, our loyal and growing customer base for their trust in our
products and our supportive shareholders for our continued success.

 

Thomas Melchior

Chief Executive Officer

Zenova Group PLC
6 June 2024

 

Dividends

The Company has not declared or paid cash dividends on the existing ordinary
shares during the current period or subsequently.

The payment of any future dividends on the ordinary shares will depend on the
future earnings of the Company. The Board has no current intention of paying a
cash dividend to Shareholders as the Board currently intends to invest the
Company's cash reserves and any cash generated into driving business growth
but will consider declaring a dividend only when prudent to do so and in the
context of the cash generated by the business.

 

Consolidated Statement of Comprehensive Income

                                       Year ended    Year ended 30 November

                                       30 November   2022

                                       2023          £'000

                                       £'000
                              Note
 Revenue                               278           175

 Cost of sales                5        (216)         (67)

 Gross profit                          62            108

 Administrative expenses      5&6      (2,107)       (2,130)

 Operating loss                        (2,045)       (2,022)

 Finance cost                 5        (18)          (10)

 Loss before taxation                  (2,063)       (2,032)

 Taxation                     7        376           -

 Loss after taxation                   (1,687)       (2,032)

 Basic loss per share         8        (1.69p)       (4.79p)
 Diluted loss per share       8        (1.69p)       (4.79p)

 

 

Consolidated Statement of Financial Position

                                                                      Note                                                    30 November 2022

 Company Number: 13403221                                                   30 November 2023
                                                                            £'000                                             £'000
 ASSETS
 NON-CURRENT ASSETS
 Goodwill                                                             9     2,346                                             2,346
 Property, plant & equipment                                          10    6                                                 9
 Right of use asset                                                   11    89                                                119
 TOTAL NON-CURRENT ASSETS                                                   2,441                                             2,474
 CURRENT ASSETS
 Inventory                                                            12                           155                                                 51
 Trade and other receivables                                          13    153                                               292
 Cash and cash equivalents                                            18    98                                                                    782
 TOTAL CURRENT ASSETS                                                       406                                               1,125
 TOTAL ASSETS                                                               2,847                                             3,599
 LIABILITIES
 NON-CURRENT LIABILITIES
 Payables: Amounts falling due after one year                         14    28                                                39
 Lease Liability                                                      15    93                                                121
 TOTAL NON-CURRENT LIABILITIES                                              121                                               160
 CURRENT LIABILTIES
 Payables: Amounts falling due within one year                        14    668                                               194
                                                                            668                                               194
 TOTAL LIABILITIES                                                          789                                               354
 NET ASSETS                                                                 2,058                                             3,245

 EQUITY
 Share capital                                                        16    106                                                                  94
 Share premium                                                        16    6,798                                             6,310
 Other reserves                                                             (68)                                              (68)
 Share based payment reserve                                          17    73                                                161
 Retained earnings                                                          (4,851)                                           (3,252)
 TOTAL EQUITY                                                               2,058                                             3,245

 

 

Consolidated Statement of Cash Flows

                                                                                           Year ended 30 November 2023  Year ended 30 November 2022
                                                                                           £'000                        £'000

 CASH FLOWS USED IN OPERATING ACTIVITIES
 Loss for the period after tax                                                             (1,687)                      (2,032)
 Adjustment for :
 Finance costs                                                                             18                           10
 Depreciation                                                                              33                           34

 Adjustments for changes in working capital
               Inventory                                                                   (105)                        (51)
 Trade and other receivables                                                               139                          (119)
 Rights of use asset                                                                       -                            30
 Trade and other payables                                                                  464                          (51)
 Lease Liability                                                                           (27)                         27
 Interest paid                                                                             (18)                         -

 NET CASH FLOW USED IN OPERATING ACTIVITIES                                                (1,183)                      (2,152)

 CASH FLOW USED IN INVESTING ACTIVITIES
 Additions to property, plant and equipment                                                (1)                          (1)
 NET CASH FLOW USED IN INVESTING ACTIVITIES                                                (1)                          (1)

 CASH FLOW FROM FINANCING ACTIVITIES
 Issue of share capital                                                                    500                          -
 NET CASH FLOW FROM FINANCING ACTIVITIES                                                   500                          -

 (DECREASE) / INCREASE IN CASH AND CASH EQUIVALENTS                                        (684)                        (2,153)

 CASH AND CASH EQUIVALENTS AT THE START OF YEAR/PERIOD                                     782                          2,936
 CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR/PERIOD                                   98                           782

 

Consolidated Statement of Changes in Equity

                                                   Share Capital  Share Premium  Share Based Payment Reserve  Other Reserve  Accumulated Losses  Total Equity

                                                   £'000          £'000          £'000                        £'000          £'000               £'000

 Balance at 30 November 2021                       94             6,310          161                          (68)           (1,218)             5,279

 Loss and total comprehensive loss for the period  -              -              -                            -              (2,032)             (2,032)
 Balance at 30 November 2022                       94             6,310          161                          (68)           (3,252)             3,245

 Transfer arising from warrants exercised          -              -              (88)                         -              88                  -
 Share Issue                                       12             488            -                            -              -                   500
 Loss and total comprehensive loss for the period  -              -              -                            -              (1,687)             (1,687)
 Balance at 30 November 2023                       106            6,798          73                           (68)           (4,851)             2,058

 

Statement of Financial Position of the Parent Company

 Company Number: 13403221                                           Notes

                                                                           30 November 2023   30 November 2022
                                                                           £'000              £'000
 ASSETS
 NON-CURRENT ASSETS
 Investments                                                        20     2,776              2,776
 Property, plant and equipment                                                                2

                                                                           2
 TOTAL NON-CURRENT ASSETS                                                  2,778              2,778
 CURRENT ASSETS
 Trade and other receivables                                        13     2,838              2,058
 Cash and cash equivalents                                          18     45                 692
 TOTAL CURRENT ASSETS                                                      2,883              2,750
 TOTAL ASSETS                                                              5,661              5,528
 LIABILITIES
 CURRENT LIABILTIES
 Payables: Amounts falling due within one year                      14                        141

                                                                           390
 TOTAL LIABILITIES                                                         390                141
 NET ASSETS                                                                5,271              5,387
 EQUITY
 Share capital                                                      16     106                94
 Share premium                                                      16     6,798              6,310
 Share based payment reserve                                        17     73                 161
 Retained earnings                                                         (1,706)            (1,178)
 TOTAL EQUITY                                                              5,271              5,387

 

 

Statement of changes in Equity of the Parent Company

                                                                              Share Capital  Share Premium  Share based payment reserve  Accumulated losses  Total equity

                                                                              £'000          £'000          £'000                        £'000               £'000

                            Balance at 30 November 2021                       94             6,310          161                          (536)               6,029

                            Loss and total comprehensive loss for the period  -              -              -                            (642)               (642)
                            Balance at 30 November 2022                       94             6,310          161                          (1,178)             5,387

 Transfer arising from warrants exercised                                     -              -              (88)                         88                  -
 Share issue                                                                  12             488            -                            -                   500
 Loss and total comprehensive loss for the period                             -              -              -                            (616)               (616)
 Balance at 30 November 2023                                                  106            6,798          73                           (1,706)             5,271

 

 

Notes to consolidated and parent company financial statements

1.   General Information

The principal activity of Zenova Group plc and its subsidiary and associate
companies (collectively "Zenova Group" or "Group") is development,
manufacture, and sale of fire-retardant systems.

Zenova Group plc is the Group's ultimate Parent Company ("the parent
company").  It is incorporated in England and Wales and domiciled in
England.  The address of its registered office is 172 Arlington Road London
NW1 7HL.  Zenova Group plc shares are admitted to trading on the London Stock
Exchange's AIM market. Zenova Group Plc is a public limited company, limited
by shares.

2.   Basis of Preparation

The functional and presentation currency is the Pound Sterling.

Consolidated Financial Statements

These consolidated financial statements have been prepared in accordance with
UK-adopted international accounting standards.  IFRS includes Interpretations
issued by the IFRS Interpretations Committee.

The consolidated financial statements have been prepared under the historical
cost convention, apart from financial assets and financial liabilities are
recorded at fair value through the profit and loss.

The preparation of financial statements in compliance with UK-adopted IFRS
requires the use of certain critical accounting estimates. It also requires
the Directors to exercise judgement in applying the Zenova's accounting
policies. The areas where significant judgements and estimates have been made
in preparing the financial statements are disclosed in more detail and the
critical accounting judgements are described in Note 3.

Parent Company Financial Statements

The parent company financial statements of Zenova Group plc have been prepared
in accordance with Financial Reporting Standard 101, 'Reduced Disclosure
Framework' (FRS 101).  The financial statements have been prepared under the
historical cost convention, and in accordance with the Companies Act 2006, as
applicable to Companies using FRS 101.

The preparation of the parent company's financial statements in conformity
with FRS 101 requires the use of certain critical accounting estimates. It
also requires management to exercise its judgement in the process of applying
the company's accounting policies.  The areas involving a higher degree of
judgement or complexity, or areas where assumptions and estimates are
significant to the financial statements are disclosed within the associated
accounting policy in Note 3.

The following exemptions from the requirements of IFRS have been applied in
the preparation of the parent company financial statements, in accordance with
FRS 101:

·    Paragraphs 45(b) and 46 to 52 of IFRS 2, 'Share-based payment'
(details of the number and weighted-average exercise prices of share options,
and how the fair value of goods or services received was determined).

·    IFRS 7, 'Financial Instruments: Disclosures'.

·    Paragraph 38 of IAS 1, 'Presentation of financial statements'
comparative information requirements in respect of: (i) paragraph 79(a)(iv) of
IAS 1; (ii) paragraph 73(e) of IAS 16 Property, plant and equipment; (iii)
paragraph 118(e) of IAS 38 Intangible assets (reconciliations between the
carrying amount at the beginning and end of the period)

·    The following paragraphs of IAS 1, 'Presentation of financial
statements': 10(d), (statement of cash flows) 16 (statement of compliance with
all IFRS), 38A (requirement for minimum of two primary statements, including
cash flow statements), 38B-D (additional comparative information), 111 (cash
flow statement information), and 134-136 (capital management disclosures)

·    IAS 7, 'Statement of cash flows'

·    The requirements in IAS 24, 'Related party disclosures' to disclose
related party transactions entered between two or more members of the Group,
provided that any subsidiary which is party to the transaction is wholly
owned.

·    The requirements of paragraph 17 of IAS 24, 'related party
transactions'

The accounting policies set out below have been applied consistently across
the Group and to all periods presented in these financial statements.

3.   Significant accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies adopted in preparation of these financial
statements are set out below. These policies have been consistently applied to
all periods, unless otherwise stated.

 

Going concern

In the year to 30 November 2023 the Group reported a loss after taxation of
£1.69m.  Net current liabilities at 30 November 2023 were £0.26m.

The Group assesses at each reporting date whether it is a going concern for a
period of at least 12 months. In making this assessment management considers:

(a) the current working capital position and operational requirements;

(b) the timing of expected sales receipts and completion of existing orders;

(c)  the sensitivities of forecast sales figures over the going concern
review period;

(d) the timing and magnitude of planned expenditure; and

(e) the level of indebtedness of the Group and timing of when such liabilities
may fall due, and accordingly the working capital position over the next 12
months.

Management considers in detail the going concern assessment, including the
underlying assumptions, risks and mitigating actions to support the
assessment. The assessment is subject to estimation uncertainty and there is
judgement in determining underlying assumptions.

There are several scenarios which management have considered that could impact
the financial performance of the Group. These include:

(a) Disruption of the supply chain, and any delays in the supply of raw
material that may impact the ability of the Group to produce its products.

(b) Delays in testing and certification required for geographical and sector
specific expansion.

(c)  Failure of the sales contracts to be realised and expected sales growth
to fall below expectations.

(d) Changes in legislation that may increase lead times in production or
testing.

(e) Intellectual property on which the Group may be reliant to keep its
competitive advantage could be challenged.

(f)  Significant negative market events or changes in investor appetite which
could delay or hinder any planned capital raising.

In performing the going concern assessment, management have prepared five
scenarios ranging from an upside scenario to a severe but plausible downside
scenario.  The scenarios make varying assumptions about the speed at which
the Group will secure new orders based on probabilities assigned to the
current sales pipeline.  In the scenario considered to reflect a severe but
plausible downside, the Directors have profiled cash balances over the coming
12 months on the basis that sales continue at levels achieved in FY23 and that
new contracts are not won or are delayed.

If the cash receipts from sales are lower than anticipated the Group has
identified that it has available to it a number of contingent actions, that it
can take to mitigate the impact of a downside scenario. In a severe but
plausible downside scenario the Group will be required to draw on one or more
of these mitigating actions to meet the Group's projected cash requirements in
the going concern review period.

These mitigating measures include seeking additional fundraising through the
issue of new shares, obtaining cash credits in respect of R&D expenditure
and through achieving further cost savings.

In respect of any potential fundraising, after consulting the Company's
brokers the Directors are confident of raising sufficient net proceeds to
cover the projected working capital requirements during the review period.

In respect of R&D tax credits, the Board notes the cash recovered during
the year in respect of R&D claims relating to the years ended 30 November
2021 and 30 November 2022.  Whilst any future R&D claim is subject to
review and approval by HMRC, the Directors are confident of the merits of a
future R&D claim in respect of expenditure incurred in the year to 30
November 2023.

The key element of cost saving mitigations is in respect of Director
remuneration.  Since December 2022, all Directors as well as certain
employees and consultants have agreed to defer 50% of their contractual
salaries until such time as the Group achieves a set level of monthly revenue
sufficient to enable to it make full or partial repayment.  The Company has
received confirmations from all Directors that they are willing to defer 100%
of their salaries if necessary to support the Group's cash requirements during
the going concern review period.

The Directors are confident that the Group will be able to meet its ongoing
working capital requirements from new orders, but also consider that in a
severe but plausible downside scenario there are sufficient options to enable
the Group to continue to meet its cash requirements should that scenario
arise.

In conclusion, having regard to the existing and future working capital
position and projected sales the Directors are of the opinion that the
application of the going concern basis is appropriate, however for the reasons
noted above, they acknowledge the existence of a material uncertainty which
may cast significant doubt over the Group's and Company's ability to continue
in operation.

Critical accounting estimates and judgements

The Group makes certain estimates and assumptions in the preparation of
financial statements. Estimates and judgements are continually evaluated based
on historical experience and other factors, including expectations of future
events that are believed to be reasonable that best reflects the conditions
and circumstances that exist and the reporting date.

The principal estimates are judgements that could have effect upon the Group's
financial results are the valuation of investments, goodwill impairment and
recoverability of receivables including loans to subsidiaries. Further details
of these estimates and judgements are set out in the related accounting
policies for these items.

Revenue recognition

The Group recognises revenue on the transfer of goods and services in
accordance with the contractual terms entered into with clients.

The revenue recognition policy is that revenue is recognised when goods are
received by the customer. Typical payment terms provide for payment are 30
days after delivery.

Segment reporting

IFRS 8 requires that an entity disclose financial and descriptive information
about its reportable segments, which are operating segments or aggregations of
operating segments. Operating segments are identified on the basis of internal
reports that are regularly reviewed by the Board to allocate resources and to
assess performance. Using the Group's internal management reporting as a
starting point the single reporting segment set out in Note 4 has been
identified.

Foreign currency transaction and balances

In preparing the financial statements of the Group, transactions in currencies
other than the Group's functional currency (foreign currencies) are recorded
at the rates of exchange prevailing on the dates of the transaction. At each
reporting date, monetary assets and liabilities that are denominated in
foreign currencies are retranslated at the rates prevailing on the balance
sheet date.

Exchange differences arising on the settlement of monetary items, and on the
retranslation of monetary items are included in statement of total
comprehensive income for the period in operation expenses.

Tax

The tax expenses for the period represents the sum of the tax currently
payable and the deferred tax charge.

Deferred tax is the tax expected to be payable or recoverable on differences
between the carrying amounts of assets and liabilities in the financial
statements and the corresponding tax bases used in the computation of taxable
profit. Deferred tax liabilities are generally recognised for all taxable
temporary differences and deferred tax assets are recognised to the extent
that it is probable that taxable profits will be available against which
deductible temporary differences can be utilised.

The carrying amount of deferred tax assets are reviewed at each reporting date
and reduced to the extent that it is no longer probable that sufficient
taxable profits will be available to allow all or part of the asset to be
recovered. Deferred tax is calculated at the tax rates that are expected to
apply in the period when the liability is settled, or the asset is realised.

Deferred tax assets and liabilities are offset where there is a legally
enforceable right to set of current tax assets against current tax liabilities
and when the relate to income taxes levied by the same taxation authority and
the Group intends to settle its current tax assets and liabilities on a net
basis.

Goodwill

The Group's goodwill relates entirely to the acquisition of Zenova
Distribution Limited

Goodwill arising on the acquisition of an entity represents the excess of the
cost of acquisition over the Group's interest in the net fair value of the
identifiable assets, liabilities and contingent liabilities of the entity
recognised at the date of acquisition. Goodwill is initially recognised as an
asset at cost and is subsequently measured at cost less any accumulated
impairment losses. Goodwill is not subject to amortisation but is tested for
impairment annually or whenever there is evidence that it may be impaired.
Goodwill is denominated in the currency of the acquired entity and revalued to
the closing exchange rate at each reporting period date.

Details of significant judgements applied in the goodwill impairment test are
given in Note 9.

Property, Plant and Equipment

Property, plant and equipment are stated at cost less accumulated depreciation
and any impairment losses.  The cost of an item of property, plant and
equipment comprises its purchase price and any directly attributable costs of
bringing the asset to its working condition and location for its intended
use.  Expenditure incurred after items of property, plant and equipment have
been put into operation, such as repairs and maintenance, is normally charged
to profit or loss in the period in which it is incurred.  In situations where
it can be clearly demonstrated that the expenditure has resulted in an
increase in the future economic benefits expected to be obtained from the use
of an item of property, plant, and equipment, and where the cost of the item
can be measured reliably, the expenditure is capitalised as an additional cost
of that asset or as a replacement.

Depreciation of items of property, plant and equipment, is calculated on the
straight-line basis to write off the cost of each item of property, plant and
equipment to its residual value over its estimated useful life.

The estimated useful lives of property, plant and equipment are as follows:

·    Office equipment - 3-5 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other
short-term highly liquid investments that are readily convertible to a known
amount of cash and are subject to an insignificant risk of change in value.
Such investments are those with original maturities of three months or less.

Inventories

Inventories are stated at the lower of cost and net realisable value. Net
realisable value is the estimated selling price for inventories less all
estimated cost of completion and costs necessary to make the sale. The First
In First Out (FIFO) cost method is used by the Group.

Leases

The Group recognises a right-of-use asset and corresponding liability at the
date at which a leased asset is made available for use by the Group, except
for short-term leases (defined as leases with a lease term of 12 months or
less) and leases of low-value assets.  For these leases, the Group recognises
the lease payments as an operating expense on a straight-line basis over the
term of the lease.

Lease liabilities are measured at the present value of the future lease
payments, excluding any payments relating to non-lease components. Future
lease payments include fixed payments, in-substance fixed payments, and
variable lease payments that are based on an index or a rate, less any lease
incentives receivable.  Lease liabilities also take into account amounts
payable under residual value guarantees and payments to exercise options to
the extent that it is reasonably certain that such payments will be made.

The payments are discounted at the rate implicit in the lease or, where that
cannot be readily determined, at an incremental borrowing rate.

Right-of-use assets are measured initially at cost based on the value of the associate lease liability, adjusted for any payments made before inception, initial direct costs and an estimate of the dismantling, removal and restoration costs required in the terms of the lease.
The Group presents right-of-use assets in 'non-current assets' in the consolidated statement of financial position.  Subsequent to initial recognition, the lease liability is reduced for payments made and increased to reflect interest on the lease liability (using the effective interest method).
The related right-of-use asset is depreciated over the term of the lease or, if shorter, the useful economic life of the leased asset.  The lease term shall include the period of an extension option where it is reasonably certain that the option will be exercised.  Where the lease contains a purchase option the asset is written off over the useful life of the asset when it is reasonably certain that the purchase option will be exercised.

The Group remeasures the lease liability and makes a corresponding adjustment
to the related right-of-use asset whenever:

·    The lease term has changed or there is a change in the assessment of
exercise of a purchase option, in which case the lease liability is remeasured
by discounting the revised lease payments using a revised discount rate.

·    The lease payments change due to changes in an index or rate or a
change in expected payment under a guaranteed residual value, in which cases
the lease liability is remeasured by discounting the revised lease payments
using the initial discount rate (unless the lease payments change is due to a
change in a floating interest rate, in which case a revised discount rate is
used).

·    A lease contract is modified, and the lease modification is not
accounted for as a separate lease, in which case the lease liability is
remeasured by discounting the revised lease payments using a revised discount
rate.

Investments in subsidiaries

Investments in subsidiaries are held at cost less accumulated impairment.
Investments are reviewed for impairment at the balance sheet date in addition
to whenever events or circumstances indicate that the carrying amount may not
be recoverable.

 

Financial instruments

Financial assets, including trade and other receivables and cash and bank
balances are initially recognized at transaction price, unless the arrangement
constitutes a financing transaction, where the transaction is measured at the
present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective
interest method. At the end of each reporting period financial assets measured
at amortised cost are assessed for lifetime expected credit losses based on
past and forward-looking information. If an asset is impaired the impairment
loss is the difference between the carrying amount and the present value of
the estimated cash flows discounted at the asset's original effective interest
rate. The impairment loss is recognised in the Statement of Comprehensive
Income. If there is a decrease in the impairment loss arising from an event
occurring after the impairment was recognised, the impairment is reversed. The
reversal is such that the current carrying amount does not exceed what the
carrying amount would have been had the impairment not previously been
recognised. The impairment reversal is recognized in the Statement of
Comprehensive Income.

Financial assets are derecognised when (a) the contractual rights to the cash
flows from the asset expire or are settled, or (b) substantially all the risks
and rewards of the ownership of the asset are transferred to another party or
(c) despite having retained some significant risks and rewards of ownership,
control of the asset has been transferred to another party who has the
practical ability to unilaterally sell the asset to an unrelated third party
without imposing additional restrictions.

Basic financial liabilities, including trade and other payables, bank loans,
loans from fellow group companies and preference shares that are classified as
debt, are initially recognised at transaction price, unless the arrangement
constitutes a financing transaction, where the debt instrument is measured at
the present value of the future receipts discounted at a market rate of
interest.

Debt instruments are subsequently carried at amortised cost, using the
effective interest rate method.

Trade payables are obligations to pay for goods or services that have been
acquired in the ordinary course of business from suppliers. Trade payables are
recognised initially at transaction price and subsequently measured at
amortised cost using the effective interest method. Financial liabilities are
derecognised when the liability is extinguished, that is when the contractual
obligation is discharged, cancelled or expires.

Reserves

·    Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

·    Share premium

Share premium represents the premium over nominal value at which shares are issued less costs associated with the issue of shares.

·    Other reserves

Other reserves represent the merger reserve created on acquisition of Zenova
Limited as part of the share reorganisation.

·    Retained earnings

Retained earnings represents the company's profits and losses which have
accumulated year on year since the Company began trading.

·    Share based payment reserve

The share based payment reserve reflects fair value of share based payments in
scope of IFRS 2 in respect of instruments which have not expired, lapsed or
been exercised at the reporting date.

Equity settled transactions

The Group has entered into equity settled share-based payments as
consideration for services received. Equity settled share-based payments are
measured at fair value at the date of grant.

The Group has measured the fair value by reference to the equity instruments
issued as it is not possible to measure reliably the fair value of the
services received.

The fair value of share options and warrants are recognised in the profit and
loss over the vesting period by reference to the expected number of
instruments expected to vest at the reporting date.

Basis of consolidation

The Group financial statements consolidate those of Zenova Group Plc (the
"Company") and its subsidiaries.  The parent company financial statements
present information about the Company as a separate entity and not about its
group.

The consolidated financial statements incorporate the financial information of
Zenova Group Plc and its subsidiaries Zenova Limited and Zenova Distribution
Limited.

Subsidiaries are all entities (including structured entities) over which the
Group has control.  The Group controls an entity when the Group is exposed
to, or has rights to, variable returns from its involvement with the entity
and can affect those returns through its power over the entity.  Further to
this, subsidiaries are entities for which the Group has the power to govern
the financial and operating policies and consistent accounting policies have
been adopted across the Group.  Subsidiaries are fully consolidated from the
date on which control is transferred to the Group. They are deconsolidated
from the date that control ceases.  The acquisition method of accounting is
used to account for business combinations by the Group.

Inter-company transactions, balances and unrealised gains on transactions
between group companies are eliminated.  Unrealised losses are also
eliminated, unless the transaction provides evidence of an impairment of the
transferred asset.  Accounting policies of subsidiaries have been changed
where necessary to ensure consistency with the policies adopted by the Group.

 

The impact of new IFRSs adopted during the year

During the year the Group adopted the following IFRS amendments and standards
for the first time:

·    Onerous contracts (Amendments to IAS 37)

·    Property, plant and equipment (Amendments to IAS 16)

·    Annual Improvements 2018-2020 cycle (IFRS 1, IFRS 9, IFRS 16 and IAS
41), and

·    References to Conceptual Framework (Amendments to IFRS 3)

New standards, interpretations and amendments not yet effective

The following IFRSs and amendments have been issued by the IASB but are not
effective until a future period.

·    IFRS 17 Insurance Contracts and Initial Application of IFRS 17 and
IFRS 9, Comparative Information (Amendments to IFRS 17)

·    Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS
Practice Statement 2)

·    Definition of Accounting Estimates (Amendments to IAS 8)

·    Deferred Tax Relating to Assets and Liabilities arising from a Single
Transaction (Amendments to IAS 12)

·    IFRS 16 Leases (Amendment, Liability in a Sale and Leaseback) (not
yet endorsed by the UK Endorsement Board)

·    IAS 1 Presentation of Financial Statements (Amendments to
Classification of Liabilities as Current or Non-current) (not yet endorsed by
the UK Endorsement Board)

·    IAS 1 Presentation of Financial Statements (Amendment to Non-current
liabilities with covenants).

The Board are currently assessing the impact of these new amendments on the
group's financial reporting for future periods.  However, the Board does not
expect any of the above to have a material impact future results.

4.   Segment information

At present the Group is considered to have only one segment being the sale and
distribution of fire safety products.

Revenue

The revenue for the year ended 30 of November was £278k (2022: £175k).

Revenue analysed by geographical market:

 Revenue analysed per geographical market      Year ended 30 November 2023  Year ended 30 November 2022

                                               £'000                        £'000
 UK                                            108                          175
 Europe                                        115                          -
 Rest of the world                             55                           -
 Total Revenue

                                               278                          175

There were 5 customers (2022: 4 customers) individually that comprised more
than 10% of the revenue. These customers contributed revenue of £238k (2022:
£147k)

5.   Expenses by nature

 Group                                                       Year ended 30 November 2023  Year ended 30 November 2022

                                                             £'000                        £'000
 Operating loss is stated after charging/(crediting):
 Cost of materials sold                                      216                          67
 Fees payable to Company's auditors                          30                           59
 Professional fees                                           211                          209
 Admin Expenses                                              41                           54
 Other costs                                                 94                           6
 Consultancy fees                                            274                          235
 Travel & entertainment                                      62                           79
 Staff Costs                                                 621                          795
 IT, Telephones and Communication                            42                           17
 Marketing & Material                                        54                           153
 Rent & Rates                                                56                           65
 R&D                                                         505                          398
 Depreciation                                                33                           34
 Other staff costs                                           84                           26
 Finance cost                                                             18                           10
 Cost of sales, administrative and operational expenses

                                                             2,341                        2,207

 

The analysis of auditors' remunerations is as follows:

 Group                                                                  Year ended 30 November 2023  Year ended 30 November 2022

                                                                        £'000                        £'000
 Fees payable to the Company's auditors for services to the group:
 Audit of the group and parent financial statements                     30                           44

 Total audit services                                                   30                           44

 

6.   Directors and employees

The Employee benefit expenses during the year were as follows:

 Group                      Year ended 30 November 2023  Year ended 30 November 2022

                            £'000                        £'000
 Wages and salaries         577                          709
 National insurance         37                           78
 Pension contributions      7                            8
                            621                          795

 

The monthly average number employed during the year were as follows:

 Group          Year ended 30 November 2023  Year ended 30 November 2022
 Directors      5                            5
 Employees      6                            3
                11                           5

 

 Company      Year ended 30 November 2022                                     Period ended 30 November 2022
 Directors                                   5                                5
 Employees    1                                                               1
              6                                                               6

Key management personnel, as defined by IAS 24 "Related party disclosures"
have been identified as the Board of Directors. Detailed disclosures of
Directors remuneration, Directors' transactions, and Directors interests and
share options for those Directors who served during the year are set out
below:

 

 Group                                          Year ended 30 November 2023  Year ended  30 November 2022

                                                £'000                        £'000
 Salary                                         284                          372
 Consultancy Fees                               164                          40
 Aggregate emoluments payable to directors      448                          412

The highest paid director's emoluments were as follows:

 Group                                   Year ended 30 November 2023     Year ended  30 November 2022

                                         £'000                           £'000
 Salary                                  103                             125
 Total amount of emoluments payable      103                             125

Remuneration in respect of the Directors was as follows:

 Year ended 30 November 2023      Salary   Consultancy Fees  Benefits  Share     Total

                                           £'000                       Options

                                  £'000                      £'000     £'000     £'000
 Executive Directors
 Tony Crawley                     102      -                 1         -         103
 Thomas Melchior                  -        99                -         -         99
 Don Nicolson                     72       -                 -         -         72
                                  174      99                1         -         274
 Non-Executive Directors
 Alain Gottesman                  35       -                 -         -         35
 Fiona Rodford                    39       -                 -         -         39
 Etrur Albani                     35       65                -         -         100
                                  109      65                -         -         174
 Total                            283      164               1         -         448

 

Benefits represents pension contributions. The number of directors to whom
pension benefits accrued in the year was 1 (2022: 1).

 

 Year ended 30 November 2022      Salary   Consultancy Fees  Benefits  Share     Total

                                           £'000                       Options

                                  £'000                      £'000     £'000     £'000

 Executive Directors
 Tony Crawley                     125      -                 -         -         125
 Thomas Melchior                  -        40                -         -         40
 Don Nicolson                     80       -                 -         -         80
                                  205      40                -         -         245
 Non-Executive Directors
 Alain Gottesman                  35                                             35
 Fiona Rodford                    35                                             35
 Etrur Albani                     97                                             97
                                  167      -                 -         -         167
 Total                            372      40                -         -         412

 

During the year, and continuing as at date of approval of these financial
statements, certain directors have agree to defer salaries at a rate of 50%
until such time as the Group has sufficient cash to repay outstanding balances
and resume full salary payment by referenced to an agreed revenue target. In
May 2024 the Directors undertook to defer 100% of future salary payments if
the Group so requires as part of the Group's cash preservation strategy. At
the year end £158,767 (2022: Nil) was payable to persons who are directors at
the balance sheet date in respect of deferred salaries. At that date £91,459
(2022: Nil) was payable to former directors in respect of deferred salaries.

No share options were awarded to directors in the year (2022: none) and no
directors exercised share options in the year (2022: none).

 

7.   Taxation

The tax on the Group's loss before tax differs from the theoretical amount
that would arise using the weighted average tax rate applicable to losses of
the Group as follows:

                                                                                   Year ended            Year ended                 30 November 2022

                                                                                   30 November 2023      £'000

                                                                                   £'000
 Reconciliation of effective tax rate
 Loss before income tax                                                            2,063                 2,032
 Tax calculated at applicable tax rates of 19%

                                                                                   309                   386
 Tax effect of expenses that are not deductible in determining taxable profit      -                     -
 Deferred tax asset not recognised in respect of losses                            (309)                 (386)
 R&D and Corporate tax credits received during the year                            (376)                 -
 Total tax charged / (credit) for the year                                         (376)                 -

With effect from 1 March 2023 the headline rate of UK tax rose to 25%, with a
small profits rate of 19% and marginal relief in between. As the company has
not yet reported a profit, the small profits rate has been applied for purpose
of the tax reconciliation. Accordingly, the Company's losses for this
accounting year are taxed at an effective rate of 19% (2022 - 19%).

As at 30 November 2023, the group had estimated tax losses of £3.9m (2022:
£3.3m) in respect of which a deferred tax asset of £1m (2022: £0.8m) has
not been recognised due to uncertainty over the availability and timing of
future taxable profits. The losses have no expiry date.

8.   Earnings per share

                                                                                Year ended 30 November 2023  Year ended 30 November 2022

                                                                                £'000                        £'000
 Loss for the year used for the calculation of basic EPS                        1,687                        2,032

 Number of shares
 Weighted average number of ordinary shares for the purpose of basic EPS        99,847,978                   42,408,348
 Effect of potentially dilutive ordinary shares                                 -                            -
 Weighted average number of ordinary shares for the purpose of diluted EPS      99,847,978                   42,408,348

 Loss per share
 Basic                                                                          (1.69p)                      (4.79p)
 Diluted                                                                        (1.69p)                      (4.79p)

Basic earnings per share is calculated by dividing the loss attributable to
owners of the Group by the weighted average number or ordinary shares in issue
during the year.

9.   Goodwill

 Group                    Goodwill

                          £'000
 Net Book Value
 At 1 December 2021       2,346
 Additions                -
 At 30 November 2022      2,346
 Additions                -
 At 30 November 2023      2,346

 

Goodwill represents the access to new distribution networks arising from the
group's acquisition of Zenova Distribution Limited. Goodwill is allocated to a
single cash generating unite which is the entire Zenova group. The directors
performed an impairment test by reference to value in use, using a discounted
cash flow model. In performing this assessment, the directors have made
certain assumptions about the ability of the group to win new orders and grow
its distribution channels. The impairment test assumes a strong growth in
revenues and profits in excess of growth achieved during the year. Based on
the signing of new distribution agreements, the award of additional
certifications and the signing of new orders, as well as review of the group's
sales pipeline and marketing strategy, the Board are satisfied that the
assumptions used are reasonable and achievable. The Board have also had regard
to the size of the global market for its products and the nature of the
group's competitive advantages. The Board's forecasts cover a period of 5
years and apply a discount rate of 14% which is derived discount rates applied
by companies with similar risk profiles. The Board are conscious that if sales
do not grow as anticipated, future goodwill impairment might result in
impairments being recorded. The impairment test resulted in significant
headroom above the carrying value of the assets tested.

10. Property Plant and Equipment

 Group                    Office Equipment  Total Property, Plant and Equipment

                          £'000             £'000
 Cost
 At 1 December 2021       9                 9
 Additions                4                 4
 At 30 November 2022      13                13
 Additions                1                 1
 At 30 November 2023      14                14

 Depreciation
 At 1 December 2021       1                 1
 Charge for the year      3                 3
 At 30 November 2022      4                 4
 Charge for the year      4                 4
 At 30 November 2023      8                 8

 Net book value
 At 1 December 2021       8                 8
 At 30 November 2022      9                 9
 At 30 November 2023      6                 6

 

11. Right of use asset

 Group                    As at 30 November                  2023                   As at 30 November 2022

                          £'000                                                     £'000
 Cost                     157                                                       157

 Depreciation
 Opening balance          38                                                        8
 Charge for the year      30                                                        30
 Closing balance          68                                                        38

 Net book value           149                                                       119

12. Inventory

 Group          As at 30 November                  2023                   As at 30 November 2022

                £'000                                                     £'000
 Inventory      155                                                       51

 

The cost of inventories recognised as expense in the year was £67,393 (2022:
£216,583).

13. Trade and other receivables

 Group                                               As at 30 November                  2023                       As at 30 November 2022

                                                     £'000                                                         £'000
 Current assets
 Trade receivable                                    165                                                           12
 Less: provision for credit loss on receivables      99                                                            6
 Trade receivables (net)                             66                                                            6

 VAT Recoverable                                     -                                                             14
 Other receivables                                   87                                                            272
 Total current receivables                           153                                                           292

 Company                                             As at 30 November                                             As at 30 November 2022

                                                     2023                                                          £'000

                                                     £'000
 Current assets
 Amounts due from group companies (Note 21)          2,817                                                         2,029
 VAT recoverable                                     -                                                             10
 Other                                               21                                                            19
                                                     2,838                                                         2,058

Information about the impairment of trade receivables and the Group's exposure
to credit risk, foreign currency risk and liquidity risk can be found in Note
18.

Trade receivables are disclosed net of a provision for bad and doubtful debts.
 The provision for bad and doubtful debts is based on specific risk
assessment and reference to past default experience.  Further details are
included in Note 18.

The Board have assessed the recoverability of the Company's investment in
subsidiaries as well as loans receivable. As the same projected cash flows are
used to perform the group goodwill impairment test, the Board consider that
the disclosure in Note 9 applies similarly to their assessment of impairment
on intercompany net investments.

14. Trade and other payables

 Group                                    As at 30 November 2023  As at 30 November 2022

                                          £'000                   £'000
 Amounts falling due after one year
 Bank Loan                                28                      39
                                          28                      39
 Amounts falling due within one year
 Trade Payables                           379                     75
 Accruals                                 39                      75
 Other payables                           250                     44
                                          668                     194

 Company                                  As at 30 November 2023  As at 30 November 2022

                                          £'000                   £'000
 Trade Payables                           217                     51
 Accruals                                 39                      67
 Other Payable                            134                     23
                                          390                     141

All trade and other payables are GBP denominated.  All foreign currency
denominated payables have been translated to GBP at the exchange rate
prevailing at 30 November 2023 and 2022.

The group holds a Bounce Bank Loan on which interest of 2.5% accrues and which
is repaid in monthly instalments over 72 months from receipt.

The directors consider that the carrying amount of trade and other payables
approximates their fair value.

15. Leases

Set out below are the carrying amount of the lease liabilities and the
movements in the period.

 Group                           As at 30 November 2023  As at 30 November 2022

                                 £'000                   £'000
 At start of the period          121                     148
 Additions                       -                       -
 Interest expense                90                      11
 Rent payments made in year      (38)                    (38)
 At 30 November                  93                      121

 

 As at 30 November 2023  Carrying amount  Contractual cash flows  6 months or less  6-12 months  1-2 years  2-5 years

                                                                  £'000

                         £'000            £'000                                     £'000        £'000      £'000
 Lease liability         93               114                     19                19           38         38

 As at 30 November 2022  Carrying amount  Contractual cash flows  6 months or less  6-12 months  1-2 years  2-5 years

                                                                  £'000

                         £'000            £'000                                     £'000        £'000      £'000
 Lease liability         119              152                     19                19           38         76

 

16. Share capital

 Group and Company   2023 Number    2022 Number    Share capital 2023  Share capital 2022  Share premium 2023  Share premium 2022

                                                   £'000               £'000               £'000               £'000
 Issued called up and fully paid ordinary shares of £0.001 each
 At 1 December       93,384,053     93,384,053     94                  94                  6,310               6,310
 Issued in the year  12,966,920     -              12                  -                   488                 -
 At 30 November      106,350,973    93,384,053     106                 94                  6,798               6,310

 

17. Share based payment reserve

During the periods presented, the Group had in issue two classes of
share-based payments being warrants issued to investors on a one-for-one bases
as part of a subscription for shares in placings, and warrants issued to
advisors in exchange for services related to the Group's Initial Public
Offering ('IPO').

No share options or warrants have been issued to Directors or employees as
remuneration for their services as Directors or Employees.

All share payments in issue are therefore termed as 'warrants'.

Where warrants are issued to investors as part on an issue of shares, the
Board consider that no services are received in exchange and therefore such
warrants are outside the scope of IFRS 2. No fair value is assigned to these
warrants as they are considered as incidental to a purchase of a share.

Where warrants were issued to advisors at the time of the Group's IPO, the
fair value of those services was determined by reference to the Black-Scholes
model and the fair value was recorded in profit or loss over the vesting
period. All warrants vested immediately other than those issued to Don
Nicolson which vest over 3 years.

The fair value of share options and warrants are recognized in profit or loss
over the vesting period by reference to the expected number of instruments
expected to vest at the reporting date. All warrants in issue are
equity-settled at a fixed exercise price. All warrants have a fixed expiry
date.

Where warrants are exercised, lapse or expire, the Group's policy is to
transfer the fair value of those warrants from the share-based payment reserve
to accumulated losses.

 

 Group and Company                                                      As at 30 November 2023  As at 30 November 2022

                                                                        £'000                   £'000
 At 1 December                                                          161                     161
 Transferred to retained earnings in respect of exercised warrants      (88)                    -
 At 30 November                                                         73                      161

 

 

 Group and Company      As at 30 November 2023                              As at 30 November

                                                                            2022
                        Average exercise price £   Number of options        Average exercise price £   Number of options
 At 1 December          £0.09                      19,094,794               £0.001                     9,338,405
 Issued                 £0.10                      12,500,000               £0.181                     9,756,389
 Exercised              £0.001                     (466,920)                -                          -
 Lapsed                 £0.19                      (7,578,944)              -                          -
 At 30 November         £0.07                      23,548,930               £0.093                     19,094,794

 

Of the 23,548,930 outstanding warrants and options (2022: 19,094,794 options),
23,548,930 options (2022: 11,097,240) were exercisable.

466,920 share options were exercised in the period 2023 (2022 - nil).
7,578,944 options lapsed or were not exercised in the year 2023 (2022 - nil).

 

Share options and warrants outstanding at the end of the period have the
following expiry dates and exercise prices:

 Warrant Holder                   Number of shares         Exercise Price    Date of issue  Expiry date
 Rockmasters Ltd                     9,338,405              £0.001           18/09/2020     18/09/2027
 Don Nicolson                         526,315               £0.19            04/03/2021     04/03/2024
 Brandon Hill Capital Limited     1,184,210                £0.19             22/07/2021     22/07/2024
 Anthony Laughton                        250,000            £0.10            14/06/2023     14/06/2026
 Landquest Group International           375,000            £0.10            14/06/2023     14/06/2026
 Gervaise Heddle                     1,250,000              £0.10            14/06/2023     14/06/2026
 Christopher Shrubb                      625,000            £0.10            14/06/2023     14/06/2026
 Christopher Wilson                      250,000            £0.10            14/06/2023     14/06/2026
 Ssas Johnson Fellowes                   250,000            £0.10            14/06/2023     14/06/2026
 Vanessa Bennett                         125,000            £0.10            14/06/2023     14/06/2026
 Matthew Pactat                          250,000            £0.10            14/06/2023     14/06/2026
 Timothy Pay                             125,000            £0.10            14/06/2023     14/06/2026
 Big Island Holdings Limited          1,250,000             £0.10            14/06/2023     14/06/2026
 SI Capital                                75,000           £0.10            14/06/2023     14/06/2026
 Clive Roberts                           375,000            £0.10            14/06/2023     14/06/2026
 Adrian Hargrave                         250,000            £0.10            14/06/2023     14/06/2026
 GIS                                     550,000            £0.10            14/06/2023     14/06/2026
 Andy Muir                            2,500,000             £0.10            14/06/2023     14/06/2026
 Hobart Capital Markets                  250,000            £0.10            14/06/2023     14/06/2026
 Subtotal                          19,798,930

 Deferred subscription agreement   Number of shares         Exercise Price   Date of issue  Expiry date
 Amati Global Investors               3,750,000             £0.10            14/06/2023     14/06/2026
 Subtotal                             3,750,000

 Grand total                       23,548,930

 

The warrants issued in the period were considered outside the scope of IFRS 2
as no services were received.

18. Capital and Financial risk management

Capital risk management

The group's objectives when managing capital are to safeguard the Group's
ability to continue as a going concern in order to provide returns for
shareholders and benefits for other stakeholders and to maintain an optimal
capital structure to reduce the cost of capital.

The capital structure of the Group consists of equity attributable to equity
holders comprising issued share capital, reserves and retained earnings as
disclosed in the Statement of Changes in Equity.

In order to maintain or adjust the capital structure, the group may adjust the
amount of dividends paid to shareholders, return capital to shareholders,
issue new shares or sell assets to reduce debt.

Consistent with others in the industry, the Group monitors capital based on
the gearing ratio and net debt/cash. This ratio is calculated as total
borrowings divided by total capital.  Net debt is calculated as total
borrowings less cash and cash equivalents.  Total capital is calculated as
'equity' as shown in the consolidated statement of financial position plus
total borrowings.

The gearing ratios at 30 November 2023 and 30 November 2022 are as follows:

 Group                      As at 30 November  As at 30 November

                            2023               2022

                            £'000              £'000
 Cash and cash equivalents  98                 782
 Net cash                   98                 782

 Loan                       28                 39

 Total equity               2,058              3,245
 Total capital              2,058              3,245
 Gearing ratio              0,0136             0,0123

 Company                    As at 30 November  As at 30 November

                            2023               2022

                            £'000              £'000
 Cash and cash equivalents  45                 692
 Net cash                   45                 692

 Total equity               5,271              5,387
 Total capital              5,271              5,387
 Gearing ratio              -                  -

 

Financial risk management

The Group is exposed to several financial risks through its normal operations,
the most significant of which are credit, foreign exchange and liquidity
risks.

The Group's overall risk management programme focuses on the unpredictability
of financial markets and seeks to minimise the potential adverse effects on
the Group's financial performance.  Risk management is carried out by the
board of directors.  The Board has established polices and principles for
overall risk management covering specific areas such as foreign exchange risk,
credit risk and investment of excess liquidity.

Credit risk

Credit risk is managed on a group basis.  The Group is responsible for
managing and analysing the credit risk for each of their new clients before
standard payment and delivery terms and conditions are offered.  Credit risk
arises from cash and cash equivalents, and deposits with banks and financial
institutions, as well as credit exposures to wholesale and retail customers,
including outstanding receivables and committed transactions.  For banks and
financial institutions, only independently rated parties with a minimum
rating of 'A' are accepted.  If wholesale customers are independently rated,
these ratings are used. If there is no independent rating, risk control
assesses the credit quality of the customer, considering its financial
position, past experience and other factors.  Sales to retail customers are
settled in cash.  For payment terms that are not met the Board raises credit
loss provisions reflective of the assessed exposure to credit risk.

The carrying amount of financial assets represents the maximum exposure. The
maximum exposure to credit risk at the reporting date was £142k (2022 -
£1074k).  Financial assets are assessed for impairment annually and a
provision for bad debt of £99k has been recognised in 2023 (2022-nil).

The Group has two types of financial assets that are subject to the expected
credit loss model:

·    trade receivables for sales of inventory

·    cash and cash equivalents

While cash and cash equivalents are subject to the impairment requirements of
IFRS 9, the identified impairment loss was immaterial.

The Group applies the IFRS 9 simplified approach to measuring expected credit
losses which uses a lifetime expected loss allowance for all trade
receivables.

Trade receivables are written off when there is no reasonable expectation of
recovery. Indicators that there is no reasonable expectation of recovery
include, amongst others, the failure of a debtor to engage in a repayment plan
with the group, and a failure to make contractual payments for a period of
greater than 120 days past due.

Impairment losses on trade receivables are presented as net impairment losses
within operating profit. Subsequent recoveries of amounts previously written
off are credited against the same line item.

The Group mitigates banking sector credit risk through the use of banks with
no lower than a single A rating.

No credit loss provision has been raised by the company in respect of its
loans to subsidiaries as a result of the assessment described in Note 9.
Intercompany loans are interest free and repayable on demand, but the parent
has undertaken not to recall such loans until the subsidiary is in a position
to repay without affecting the ability of the subsidiary to meet its projected
working capital requirements.

Foreign exchange risk

The Group operates primarily in the United Kingdom and is only exposed to very
limited amounts of foreign exchange risk arising from various currency
exposures.

There is no cash denominated in non-GBP currency as at 30 November 2023 or
2022.

Liquidity risk

Cash flow forecasting is performed in the operating entities of the group and
aggregated by group finance. Group finance monitors rolling forecasts of the
Group's liquidity requirements to ensure it has sufficient cash to meet
operational needs.

Surplus cash held by the operating entities over and above the balance
required for working capital management is transferred to the group treasury.

The table below analyses the Group's non-derivative financial liabilities
into relevant maturity groupings based on the remaining period at the balance
sheet date to the contractual maturity date.

The following are the contractual maturities of financial liabilities for the
Group as at 30 November 2023 and 30 November 2022 based upon contractual cash
flows:

 As at 30 November 2023    Carrying amount  Contractual cash flows  6 months or less  6-12 months  1-2 years  2-5 years

                                                                    £'000

                           £'000            £'000                                     £'000        £'000      £'000
 Trade and other payables  696              696                     668               -            28         -
                           696              696                     668               -            28         -

 As at 30 November 2022    Carrying amount  Contractual cash flows  6 months or less  6-12 months  1-2 years  2-5 years

                                                                    £'000

                           £'000            £'000                                     £'000        £'000      £'000
 Trade and other payables  233              233                     194               -            39         -
                           233              233                     194               -            39         -

Ultimate responsibility for liquidity risk management rests with the board of
directors, which has established an appropriate liquidity risk management
framework for the management of the Group's short-, medium-, long-term funding
and liquidity management requirements. The Group manages liquidity risk by
maintaining adequate reserves, banking facilities and reserve borrowing
facilities, by continuously monitoring forecast and actual cashflows, and by
matching the maturity profiles of financial assets and liabilities.

Fair Values

The directors have reviewed the financial statements and have concluded that,
there are no significant differences between the book values and the fair
values of the financial assets and financial liabilities of the Group and
Company as at 30 November 2023 and 30 November 2022.

19. Interests in other undertakings

                              Ownership  Date  incorporated   Registered office                             Place of incorporation  Principal Activity
 Zenova Limited               100%       20 Jan 2020          172 Arlington Road, London, England, NW1 7HL  England and Wales       Operating Company
 Zenova Distribution Limited  100%       16 Sep 2020          172 Arlington Road, London, England, NW1 7HL  England and Wales       Distribution Company

 

20. Investments

 Company                                As at 30 November 2023  As at 30 November 2022

                                        £'000                   £'000

 Shares in subsidiary undertakings      2,776                   2,776
                                        2,776                   2,776

21. Related party transactions

The executive directors are also considered key management as defined by IAS
24 'Related Party Disclosures'. The remuneration of key management is
considered in Note 6.

The Company financial statements of Zenova Group Plc include amounts
receivable from its subsidiary undertakings Zenova Limited and Zenova
Distribution Limited of £2,892k (2022 - £2,029k) and amounts payable of
£75k (2022 - £Nil).  Amounts provided to Zenova Limited and to Zenova
Distribution Limited relate to the provision of funding for operations and
capital expenditure. All intercompany loans are interest free, unsecured and
repayable on demand.

22. Contingent liabilities

At the year end, the company is the party to an active legal claim and has
identified a further potential claim arising under a historic contract. In
respect of both matters, the Board considers that the timing and amount of any
outflow is uncertain and so represents a contingent liability at the year end.

23. Controlling parties

In the opinion of the Directors, there is no single ultimate controlling
party.

24. Post Balance Sheet Events

On 15 March 2024 the Group issued 33,875,000 new ordinary shares at 2p per
share raising gross proceeds of £677,500 gross through a subscription,
earmarked for bolstering working capital.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR SSIFUMELSEFM

Recent news on Zenova

See all news